Whitehouse Station, N.J.-based Merck (MRK - Get Report) reported a profit on Tuesday of $1.64 billion, or 78 cents per share, beating out analysts predictions of earnings per share of 74 cents and revenue of $5.98 billion. The maker of numerous drugs, including Singulair, Zostavax and Fosamax, credits restricting and lower fourth-quarter costs for materials and production with boosting the bottom line.

This piece of earnings news along with a surprising spike in pending home sales in December gave the market a nice lift on Tuesday, led by such stocks as Cisco ( CSCO - Get Report), Pfizer ( PFE - Get Report) and Microsoft ( MSFT - Get Report).

But will this be enough?

With this in mind, we thought we'd take a look at some of the stocks people have been searching for on TheStreet.com and see what Jim Cramer's had to say about them lately.

To read more, visit Stockpickr.com.

Stockpickr is a wholly owned subsidiary of TheStreet.com.